82_FR_20979 82 FR 20894 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

82 FR 20894 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 85 (May 4, 2017)

Page Range20894-20895
FR Document2017-09013

Federal Register, Volume 82 Issue 85 (Thursday, May 4, 2017) 
[Federal Register Volume 82, Number 85 (Thursday, May 4, 2017)]
[Notices]
[Pages 20894-20895]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-09013]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcements (FOAs) 
GH16-006, Conducting Public Health Research in Kenya; GH17-004, 
Conducting Public Health Research Activities in Egypt; GH17-005, 
Conducting Public Health Research in China.
    Time and Date: 9:00 a.m.-2:00 p.m., EDT, May 24, 2017 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Conducting Public Health Research in Kenya'', GH16-006; 
``Conducting Public Health Research Activities in Egypt'', GH17-004; 
and ``Conducting Public Health Research in China'', GH17-005.
    Contact Person for More Information: Hylan Shoob, Scientific Review 
Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 
Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: 
(404) 639-4796.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and

[[Page 20895]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-09013 Filed 5-3-17; 8:45 am]
 BILLING CODE 4163-18-P

20894 Federal Register / Vol. 82, No. 85 / Thursday, May 4, 2017 / Notices EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of Number of Hours per Total burden Form name responses per respondents response hours respondent Primary care site patient characteristics survey .............................................. 9 1 1.5 13.5 Workflow mapping preliminary interview ......................................................... 72 1 0.5 36 Workflow mapping group interview .................................................................. 90 1 1.5 135 Workflow mapping follow-up interview ............................................................ 72 1 0.5 36 Patient interview .............................................................................................. 90 1 0.5 45 Community agency interview ........................................................................... 45 1 1 45 Total .......................................................................................................... 387 n/a n/a 2,628 hours EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN Average Number of Total burden Total cost Form name hourly wage respondents hours burden rate * Primary care site organizational characteristics survey .................................. 9 13.5 a$ 40.41 $ 545.54 Primary care site patient characteristics survey .............................................. 9 13.5 a 40.41 545.54 Workflow mapping preliminary interview ......................................................... 72 36 a 40.41 1,454.76 Workflow mapping group interview .................................................................. 90 135 a 40.41 5,455.35 Workflow mapping follow-up interview ............................................................ 72 36 a 40.41 1,454.76 Patient interview .............................................................................................. 90 45 b 23.23 1,045.35 Community agency interview ........................................................................... 45 45 c 22.20 999.00 Total .......................................................................................................... 387 n/a n/a 11,500.30 * For hourly average wage rates, mean hourly wages from the Bureau of Labor Statistics (BLS) May 2015 national occupational employment wage estimates were used. http://www.bls.gov/oes/current/oes_nat.htm#00-0000. a Participants will include a mix of providers and front desk staff; therefore a blended rate for these tasks are used including Nurse ($33.55), Medical Assistant ($15.011), Front Desk Staff ($13.382), Program Director ($32.56), Pharmacist ($56.96), Physician ($91.60), Behavioral health provider ($22.03). b Based upon the mean wages for consumers (all occupations). c Based upon the mean wages for Social Workers. Request for Comments comments will become a matter of Place: Teleconference. public record. Status: The meeting will be closed to In accordance with the Paperwork Reduction Act, comments on AHRQ’s Sharon B. Arnold, the public in accordance with information collection are requested Acting Director. provisions set forth in Section [FR Doc. 2017–08997 Filed 5–3–17; 8:45 am] 552b(c)(4) and (6), Title 5 U.S.C., and with regard to any of the following: (a) the Determination of the Director, Whether the proposed collection of BILLING CODE 4160–90–P Management Analysis and Services information is necessary for the proper Office, CDC, pursuant to Public Law 92– performance of AHRQ health care DEPARTMENT OF HEALTH AND 463. research and health care information dissemination functions, including HUMAN SERVICES Matters for Discussion: The meeting whether the information will have will include the initial review, Centers for Disease Control and discussion, and evaluation of practical utility; (b) the accuracy of Prevention AHRQ’s estimate of burden (including applications received in response to hours and costs) of the proposed Disease, Disability, and Injury ‘‘Conducting Public Health Research in collection(s) of information; (c) ways to Prevention and Control Special Kenya’’, GH16–006; ‘‘Conducting Public enhance the quality, utility and clarity Emphasis Panel (SEP): Initial Review Health Research Activities in Egypt’’, of the information to be collected; and GH17–004; and ‘‘Conducting Public In accordance with Section 10(a)(2) of Health Research in China’’, GH17–005. (d) ways to minimize the burden of the the Federal Advisory Committee Act collection of information upon the Contact Person for More Information: (Pub. L. 92–463), the Centers for Disease respondents, including the use of Hylan Shoob, Scientific Review Officer, Control and Prevention (CDC) automated collection techniques or Center for Global Health (CGH) Science announces a meeting for the initial other forms of information technology. Office, CGH, CDC, 1600 Clifton Road review of applications in response to NE., Mailstop D–69, Atlanta, Georgia Comments submitted in response to Funding Opportunity Announcements 30033, Telephone: (404) 639–4796. pmangrum on DSK3GDR082PROD with NOTICES this notice will be summarized and (FOAs) GH16–006, Conducting Public included in the Agency’s subsequent Health Research in Kenya; GH17–004, The Director, Management Analysis request for OMB approval of the Conducting Public Health Research and Services Office, has been delegated proposed information collection. All Activities in Egypt; GH17–005, the authority to sign Federal Register Conducting Public Health Research in notices pertaining to announcements of China. meetings and other committee 1 http://www.bls.gov/oes/current/oes319092.htm. Time and Date: 9:00 a.m.–2:00 p.m., management activities, for both the 2 http://www.bls.gov/oes/current/oes434171.htm. EDT, May 24, 2017 (Closed). Centers for Disease Control and VerDate Sep<11>2014 14:39 May 03, 2017 Jkt 241001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\04MYN1.SGM 04MYN1

Federal Register / Vol. 82, No. 85 / Thursday, May 4, 2017 / Notices 20895 Prevention and the Agency for Toxic DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND Substances and Disease Registry. HUMAN SERVICES HUMAN SERVICES Elaine L. Baker, Centers for Disease Control and Administration for Children and Director, Management Analysis and Services Office, Centers for Disease Control and Prevention Families Prevention. Disease, Disability, and Injury Submission for OMB Review; [FR Doc. 2017–09013 Filed 5–3–17; 8:45 am] Prevention and Control Special Comment Request BILLING CODE 4163–18–P Emphasis Panel (SEP): Initial Review Title: Center for States Evaluation DEPARTMENT OF HEALTH AND In accordance with Section 10(a)(2) of Ancillary Data Collection. HUMAN SERVICES the Federal Advisory Committee Act OMB No.: New Collection. (Pub. L. 92–463), the Centers for Disease Description: The Evaluation of the Centers for Disease Control and Control and Prevention (CDC) Child Welfare Capacity Building Prevention announces a meeting for the initial Collaborative, Center for States is review of applications in response to Disease, Disability, and Injury sponsored by the Children’s Bureau, Funding Opportunity Announcement, Prevention and Control Special Administration for Children and RFA–TS17–001, Identify and Emphasis Panel (SEP): Initial Review Families of the U.S. Department of Characterize Potential Environmental Health and Human Services. The In accordance with Section 10(a)(2) of Risk Factors for Amyotrophic Lateral purpose of this evaluation is to respond the Federal Advisory Committee Act Sclerosis (ALS). (Pub. L. 92–463), the Centers for Disease to a set of cross-cutting evaluation Time and Date: 8:00 a.m.–5:00 p.m., questions posed by the Children’s Control and Prevention (CDC) EDT, May 31, 2017 (Closed). announces a meeting for the initial Bureau. This new information collection review of applications in response to Place: Teleconference. is an ancillary part of a larger data Funding Opportunity Announcement, Status: The meeting will be closed to collection effort being conducted for the PS17–005, Strengthening HIV/AIDS the public in accordance with evaluation of the Child Welfare Capacity Research in Kenya. provisions set forth in Section Building Collaborative. Two groups of Time and Date: 10:00 a.m.–5:00 p.m., 552b(c)(4) and (6), Title 5 U.S.C., and instruments for the larger evaluation EDT, May 24, 2017 (Closed). the Determination of the Director, have already been submitted, and Place: Teleconference. Management Analysis and Services requests for clearance have been Status: The meeting will be closed to submitted to the Office of Management the public in accordance with Office, CDC, pursuant to Public Law 92– 463. and Budget (see Federal Register provisions set forth in Section Volume 80, No. 211, November 2, 2015; 552b(c)(4) and (6), Title 5 U.S.C., and Matters for Discussion: The meeting Federal Register Volume 81, No. 41, the determination of the Director, will include the initial review, March 2, 2016; Federal Register Volume Management Analysis and Services discussion, and evaluation of 81, No. 111, June 9, 2016; Federal Office, CDC, pursuant to Public Law 92– applications received in response to 463. Register Volume 81, No. 186, September ‘‘Identify and Characterize Potential Matters for Discussion: The meeting 26, 2016), with the first group of Environmental Risk Factors for ALS’’, will include the initial review, instruments approved on August 31, RFA–TS–17–001. discussion, and evaluation of 2016. This notice details a group of applications received in response to Contact Person for More Information: instruments that are specific only to the ‘‘Strengthening HIV/AIDS Research in Oscar Tarrago, M.D., M.P.H., Scientific Center for States. The instruments focus Kenya’’, PS17–005. Review Officer, CDC, 4770 Buford on (1) evaluating an innovative Contact Person for More Information: Highway NE., Mailstop F63, Atlanta, approach to engaging professionals in Gregory Anderson, M.S., M.P.H., Georgia 30341–3724, Telephone: (770) networking and professional Scientific Review Officer, CDC, 1600 488–3492. development through virtual Clifton Road NE., Mailstop E60, Atlanta, The Director, Management Analysis conferences, (2) understanding fidelity Georgia 30329, Telephone: (404) 718– and Services Office, has been delegated to and effectiveness of the Center for 8833. the authority to sign Federal Register States’ Capacity Building Model, and (3) The Director, Management Analysis capturing consistent information during notices pertaining to announcements of and Services Office, has been delegated meetings and other committee the updated annual assessment process the authority to sign Federal Register management activities, for both the focused on related contextual issues notices pertaining to announcements of meetings and other committee Centers for Disease Control and impacting potential service delivery management activities, for both the Prevention and the Agency for Toxic such as implementation of new Centers for Disease Control and Substances and Disease Registry. legislation. Prevention and the Agency for Toxic Elaine L. Baker, Respondents: Respondents of these Substances and Disease Registry. data collection instruments will include Director, Management Analysis and Services child welfare agency staff and pmangrum on DSK3GDR082PROD with NOTICES Elaine L. Baker, Office, Centers for Disease Control and Prevention. stakeholders who directly receive Director, Management Analysis and Services Office, Centers for Disease Control and [FR Doc. 2017–09015 Filed 5–3–17; 8:45 am] services. Prevention. BILLING CODE 4163–18–P [FR Doc. 2017–09014 Filed 5–3–17; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 14:39 May 03, 2017 Jkt 241001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\04MYN1.SGM 04MYN1


Document Created: 2017-05-04 01:48:56
Document Modified: 2017-05-04 01:48:56
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
Dates9:00 a.m.-2:00 p.m., EDT, May 24, 2017 (Closed).
FR Citation82 FR 20894 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR